0.05
-4.17%
Close of 6 Nov 2026, in SGD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Thomson Medical Group
Its shares trade on SGX under the ticker A50.SI. It has been listed since 8 July 2002. In the fiscal year to 30 June 2025, it reported revenue of SGD 394.7m and a net loss of SGD 47.6m. At that date it held total assets of SGD 1.78bn and shareholders' equity of SGD 470.9m.
Thomson Medical Group Ltd. engages in the healthcare and real estate business. The company employs 13 full-time employees The company went IPO on 2002-07-08. The Company’s healthcare business includes Thomson Medical, TMC Life Sciences Berhad and Vantage Bay Healthcare City. Its Thomson Medical business is engaged in providing healthcare services for women and children, which owns and operates iconic Thomson medical centre and a network of medical clinics and facilities in Singapore. Its TMC Life Sciences Berhad is a multidisciplinary healthcare service provider, which operates through Thomson Hospital Kota Damansara, TMC Fertility Centre, and Thomson Iskandar Medical Hub. Its Vantage Bay Healthcare City is a vibrant hub comprising medical facilities such as a general hospital, a specialist hospital, a community hospital and long-term care facilities. The company is also focused on developing health sciences education and training facilities, and a purpose-built urban wellness hotel and resort, incorporating retail and other related services.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 8 Jul 2002
- Employees
- 13
- Website
- thomsonmedicalgroup.com ↗
Leadership
Pay as last reported
- Mr. Ser Miang NgNon-Executive Independent Chairman of the Board
- Dr. Jun Li HengGroup Chief Executive Officer, Executive Director, since 2022
- Mr. Wee Kiat LimExecutive Vice Chairman of the Board, since 2019
- Mr. Wilson SamGroup Chief Financial Officer, Executive Director, since 2019
- Ms. Lakshmi DeviChief Executive Officer - TMC Fertility Holdings Sdn Bhd
- Dr. Jean- Marcel GuillonChief Executive Officer - Far East Medical Vietnam Limited
- Mr. Suen Ming LeeChief Executive Officer - Thomson Medical Singapore
- Mr. Mor NgChief Operating Officer
- Mr. Zing Yuen TanChief Risk and Compliance Officer
- Ms. Le Quyen TranChief Financial Officer - Far East Medical Vietnam Limited
- Mr. Yu Chee WongGroup Chief Financial Officer - TMC Life Sciences Berhad
- Ms. Soon Soo FooJoint Company Secretary
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 50
- Environment
- 23
- Social
- 86
- Governance
- 42
- Women in the workforce
- 81%
- Carbon reduction policy
- Yes
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Thomson Medical Group Ltd has a strong brand presence in the healthcare industry.
- The company possesses state-of-the-art facilities and advanced medical technology.
- Thomson Medical Group has a team of highly skilled and experienced medical professionals.
Weaknesses
- Thomson Medical Group Ltd faces intense competition from other healthcare providers.
- The company's operations are geographically limited, which may restrict its growth potential.
- Thomson Medical Group heavily relies on a few key revenue sources, posing a risk to its financial stability.
Opportunities
- The growing demand for healthcare services presents opportunities for Thomson Medical Group to expand its customer base.
- The company can explore partnerships and collaborations with other healthcare institutions to enhance its services.
- Thomson Medical Group can leverage technological advancements to improve operational efficiency and patient care.
Threats
- Changing government regulations and policies can impact Thomson Medical Group's business operations.
- Economic uncertainties and fluctuations can affect the overall demand and affordability of healthcare services.
- The emergence of new competitors in the market poses a threat to the company's market share.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.